Terumo Co. (OTCMKTS:TRUMY) Short Interest Up 271.4% in March

Terumo Co. (OTCMKTS:TRUMY - Get Free Report) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 2,600 shares, a growth of 271.4% from the March 15th total of 700 shares. Based on an average trading volume of 30,200 shares, the days-to-cover ratio is presently 0.1 days.

Terumo Stock Performance

Shares of TRUMY traded down $0.13 during mid-day trading on Thursday, hitting $16.70. The company's stock had a trading volume of 32,973 shares, compared to its average volume of 68,156. The stock's 50-day moving average is $21.37 and its two-hundred day moving average is $17.36. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.13 and a current ratio of 1.90. The firm has a market capitalization of $25.37 billion, a PE ratio of 17.58 and a beta of 0.65. Terumo has a one year low of $12.56 and a one year high of $20.60.

Terumo (OTCMKTS:TRUMY - Get Free Report) last issued its earnings results on Wednesday, February 7th. The company reported $0.14 EPS for the quarter, meeting analysts' consensus estimates of $0.14. The business had revenue of $1.62 billion during the quarter. Terumo had a return on equity of 8.26% and a net margin of 11.14%. As a group, sell-side analysts anticipate that Terumo will post 1.14 EPS for the current year.

Terumo Company Profile

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.